Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases
Marian S. Kafka, Daniel P. van Kammen, Joel E. Kleinman, John I. Nurnberger, Larry J. Siever, Thomas W. Uhde, Ronald J. Polinsky
Platelet α-adrenergic receptor function was assessed by correlating the number of α-receptors measured by the specific binding of an α-receptor antagonist, [3H]dihydroergocryptine ([3H]DHE), with an intracellular biological response, the inhibition of cyclic AMP (cAMP) production by an α-receptor agonist, norepinephrine (NE). Alpha-receptor function in adult control subjects of both sexes was compared with α-receptor function in patients with chronic schizophrenia and affective disorders. As a measurement of the specificity of α-receptor alterations in platelets from patients with schizophrenia or affective illness, platelet α-receptor function was compared in patients with other diseases in which adrenergic transmission may be altered, viz., essential hypertension, orthostatic hypotension, and Parkinson's disease. Finally, to provide a comparison group for studies of diseases of neural transmission in children, α-receptor function was measured in a group of young control males. The number of platelet α-receptors, relative to that in control subjects, was increased in patients with schizophrenia and affective illness. It was also elevated in patients with hypertension and idiopathic orthostatic hypotension (IOH), but not in patients with sympathotonic orthostatic hypotension (SOH), multiple system atrophy (MSA, Shy-Drager's Syndrome), or Parkinson's disease. When α-receptor function was compared in adult control subjects and young male controls, the number of α-receptors was similar in adult male, and young male, controls. Prostaglandin E1 (PGE1)-stimulated cAMP production in platelets was decreased in patients with schizophrenia. It was also lower in patients with hypertension and MSA, but unchanged in patients with affective illness, IOH, SOH, or Parkinson's disease. PGE1-stimulated cAMP production was similar in adult female, and young male, controls. In platelet lysates from schizophrenic patients the activity of the enzyme adenylate cyclase, which catalyzes the conversion of ATP to cAMP, was decreased. The decrease may be a major cause of decreased cAMP production in intact platelets from these patients. If the changes observed in platelets also occur in neurons, an increased number of α-receptors may play a role in the etiology of affective illness, while both an increase in the number of α-receptors and a decrease in cAMP production may play a part in the pathophysiology of schizophrenia.
Communications In Psychopharmacology
Fingerprint Dive into the research topics of 'Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases'. Together they form a unique fingerprint.
Receptors, Adrenergic, alpha Medicine & Life Sciences
Mood Disorders Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences
Blood Platelets Medicine & Life Sciences
Cyclic AMP Medicine & Life Sciences
Idiopathic orthostatic hypotension Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences
Orthostatic Hypotension Medicine & Life Sciences
Kafka, M. S., van Kammen, D. P., Kleinman, J. E., Nurnberger, J. I., Siever, L. J., Uhde, T. W., & Polinsky, R. J. (1980). Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases. Communications In Psychopharmacology, 4(6), 477-486.
Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases. / Kafka, Marian S.; van Kammen, Daniel P.; Kleinman, Joel E.; Nurnberger, John I.; Siever, Larry J.; Uhde, Thomas W.; Polinsky, Ronald J.
In: Communications In Psychopharmacology, Vol. 4, No. 6, 01.12.1980, p. 477-486.
Kafka, MS, van Kammen, DP, Kleinman, JE, Nurnberger, JI, Siever, LJ, Uhde, TW & Polinsky, RJ 1980, 'Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases', Communications In Psychopharmacology, vol. 4, no. 6, pp. 477-486.
Kafka MS, van Kammen DP, Kleinman JE, Nurnberger JI, Siever LJ, Uhde TW et al. Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases. Communications In Psychopharmacology. 1980 Dec 1;4(6):477-486.
Kafka, Marian S. ; van Kammen, Daniel P. ; Kleinman, Joel E. ; Nurnberger, John I. ; Siever, Larry J. ; Uhde, Thomas W. ; Polinsky, Ronald J. / Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases. In: Communications In Psychopharmacology. 1980 ; Vol. 4, No. 6. pp. 477-486.
@article{9d3373e66fc04640b78b0fbd7608d258,
title = "Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases",
abstract = "Platelet α-adrenergic receptor function was assessed by correlating the number of α-receptors measured by the specific binding of an α-receptor antagonist, [3H]dihydroergocryptine ([3H]DHE), with an intracellular biological response, the inhibition of cyclic AMP (cAMP) production by an α-receptor agonist, norepinephrine (NE). Alpha-receptor function in adult control subjects of both sexes was compared with α-receptor function in patients with chronic schizophrenia and affective disorders. As a measurement of the specificity of α-receptor alterations in platelets from patients with schizophrenia or affective illness, platelet α-receptor function was compared in patients with other diseases in which adrenergic transmission may be altered, viz., essential hypertension, orthostatic hypotension, and Parkinson's disease. Finally, to provide a comparison group for studies of diseases of neural transmission in children, α-receptor function was measured in a group of young control males. The number of platelet α-receptors, relative to that in control subjects, was increased in patients with schizophrenia and affective illness. It was also elevated in patients with hypertension and idiopathic orthostatic hypotension (IOH), but not in patients with sympathotonic orthostatic hypotension (SOH), multiple system atrophy (MSA, Shy-Drager's Syndrome), or Parkinson's disease. When α-receptor function was compared in adult control subjects and young male controls, the number of α-receptors was similar in adult male, and young male, controls. Prostaglandin E1 (PGE1)-stimulated cAMP production in platelets was decreased in patients with schizophrenia. It was also lower in patients with hypertension and MSA, but unchanged in patients with affective illness, IOH, SOH, or Parkinson's disease. PGE1-stimulated cAMP production was similar in adult female, and young male, controls. In platelet lysates from schizophrenic patients the activity of the enzyme adenylate cyclase, which catalyzes the conversion of ATP to cAMP, was decreased. The decrease may be a major cause of decreased cAMP production in intact platelets from these patients. If the changes observed in platelets also occur in neurons, an increased number of α-receptors may play a role in the etiology of affective illness, while both an increase in the number of α-receptors and a decrease in cAMP production may play a part in the pathophysiology of schizophrenia.",
author = "Kafka, {Marian S.} and {van Kammen}, {Daniel P.} and Kleinman, {Joel E.} and Nurnberger, {John I.} and Siever, {Larry J.} and Uhde, {Thomas W.} and Polinsky, {Ronald J.}",
journal = "Communications In Psychopharmacology",
T1 - Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases
AU - Kafka, Marian S.
AU - van Kammen, Daniel P.
AU - Kleinman, Joel E.
AU - Nurnberger, John I.
AU - Siever, Larry J.
AU - Uhde, Thomas W.
AU - Polinsky, Ronald J.
N2 - Platelet α-adrenergic receptor function was assessed by correlating the number of α-receptors measured by the specific binding of an α-receptor antagonist, [3H]dihydroergocryptine ([3H]DHE), with an intracellular biological response, the inhibition of cyclic AMP (cAMP) production by an α-receptor agonist, norepinephrine (NE). Alpha-receptor function in adult control subjects of both sexes was compared with α-receptor function in patients with chronic schizophrenia and affective disorders. As a measurement of the specificity of α-receptor alterations in platelets from patients with schizophrenia or affective illness, platelet α-receptor function was compared in patients with other diseases in which adrenergic transmission may be altered, viz., essential hypertension, orthostatic hypotension, and Parkinson's disease. Finally, to provide a comparison group for studies of diseases of neural transmission in children, α-receptor function was measured in a group of young control males. The number of platelet α-receptors, relative to that in control subjects, was increased in patients with schizophrenia and affective illness. It was also elevated in patients with hypertension and idiopathic orthostatic hypotension (IOH), but not in patients with sympathotonic orthostatic hypotension (SOH), multiple system atrophy (MSA, Shy-Drager's Syndrome), or Parkinson's disease. When α-receptor function was compared in adult control subjects and young male controls, the number of α-receptors was similar in adult male, and young male, controls. Prostaglandin E1 (PGE1)-stimulated cAMP production in platelets was decreased in patients with schizophrenia. It was also lower in patients with hypertension and MSA, but unchanged in patients with affective illness, IOH, SOH, or Parkinson's disease. PGE1-stimulated cAMP production was similar in adult female, and young male, controls. In platelet lysates from schizophrenic patients the activity of the enzyme adenylate cyclase, which catalyzes the conversion of ATP to cAMP, was decreased. The decrease may be a major cause of decreased cAMP production in intact platelets from these patients. If the changes observed in platelets also occur in neurons, an increased number of α-receptors may play a role in the etiology of affective illness, while both an increase in the number of α-receptors and a decrease in cAMP production may play a part in the pathophysiology of schizophrenia.
AB - Platelet α-adrenergic receptor function was assessed by correlating the number of α-receptors measured by the specific binding of an α-receptor antagonist, [3H]dihydroergocryptine ([3H]DHE), with an intracellular biological response, the inhibition of cyclic AMP (cAMP) production by an α-receptor agonist, norepinephrine (NE). Alpha-receptor function in adult control subjects of both sexes was compared with α-receptor function in patients with chronic schizophrenia and affective disorders. As a measurement of the specificity of α-receptor alterations in platelets from patients with schizophrenia or affective illness, platelet α-receptor function was compared in patients with other diseases in which adrenergic transmission may be altered, viz., essential hypertension, orthostatic hypotension, and Parkinson's disease. Finally, to provide a comparison group for studies of diseases of neural transmission in children, α-receptor function was measured in a group of young control males. The number of platelet α-receptors, relative to that in control subjects, was increased in patients with schizophrenia and affective illness. It was also elevated in patients with hypertension and idiopathic orthostatic hypotension (IOH), but not in patients with sympathotonic orthostatic hypotension (SOH), multiple system atrophy (MSA, Shy-Drager's Syndrome), or Parkinson's disease. When α-receptor function was compared in adult control subjects and young male controls, the number of α-receptors was similar in adult male, and young male, controls. Prostaglandin E1 (PGE1)-stimulated cAMP production in platelets was decreased in patients with schizophrenia. It was also lower in patients with hypertension and MSA, but unchanged in patients with affective illness, IOH, SOH, or Parkinson's disease. PGE1-stimulated cAMP production was similar in adult female, and young male, controls. In platelet lysates from schizophrenic patients the activity of the enzyme adenylate cyclase, which catalyzes the conversion of ATP to cAMP, was decreased. The decrease may be a major cause of decreased cAMP production in intact platelets from these patients. If the changes observed in platelets also occur in neurons, an increased number of α-receptors may play a role in the etiology of affective illness, while both an increase in the number of α-receptors and a decrease in cAMP production may play a part in the pathophysiology of schizophrenia.
JO - Communications In Psychopharmacology
JF - Communications In Psychopharmacology